Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs

Wong, 2004, Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome, Clin Exp Immunol, 136, 95, 10.1111/j.1365-2249.2004.02415.x

Mahallawi, 2018, MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile, Cytokine, 104, 8, 10.1016/j.cyto.2018.01.025

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5

Liu, 2020, Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro, Cell Discov, 6, 16, 10.1038/s41421-020-0156-0

Ferner, 2020, Chloroquine and hydroxychloroquine in covid-19, BMJ, 369, m1432, 10.1136/bmj.m1432

Richardson, 2020, Baricitinib as potential treatment for 2019-nCoV acute respiratory disease, Lancet, 395, e30, 10.1016/S0140-6736(20)30304-4

European League Against Rheumatism (EULAR). EULAR Guidance for patients COVID-19 outbreak. Available from: https://www.eular.org/eular_guidance_for_patients_covid19_outbreak.cfm. [Accessed April 28 2020].

American College of Rheumatology (ACR). COVID-19 Clinical Guidance for Adult Patients with Rheumatic Diseases. Available from: https://www.rheumatology.org/Announcements#ClinicalGuidance. [Accessed April 28 2020].

National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders (NG167). Available from: https://www.nice.org.uk/guidance/ng167. [Accessed April 28 2020].

Paediatric Rheumatology European Association (PRES). PRES recommendations for coronavirus outbreak. Available from: https://www.pres.eu/news/newsstory.html?id=29. [Accessed April 28 2020].

Monti, 2020, Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies, Ann Rheum Dis, 10.1136/annrheumdis-2020-217424

Favalli, 2020, Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis, J Rheumatol, 10.3899/jrheum.200507

Filocamo, 2020, Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs, J Rheumatol, 10.3899/jrheum.200483

Robinson, 2020, The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic, Nat Rev Rheumatol, 10.1038/s41584-020-0418-0

Gianfrancesco, 2020, Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries, Lancet Rheumatol

Sub-direcció General de Vigilància i Resposta a Emergències de Salut Pública. Procediment d'actuació enfront de casos d'infecció pel nou coronavirus SARS-CoV-2. Available from: http://canalsalut.gencat.cat/coronavirus. [Accessed 28/04/2020]

World Health Organisation (WHO). Global surveillance for COVID-19 caused by human infection with COVID-19 virus: interim guidance. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/surveillance-and-case-definitions. [Accessed 28/04/2020]

Agència de Salut Pública de Barcelona (ASPB). Dades diàries de la infecció per coronavirus SARS-CoV-2 (COVID-19) a Barcelona. Available from: https://www.aspb.cat/docs/COVID19aldiaBCN/ [Accessed 28/04/2020]

Ludvigsson, 2020, Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults, Acta Paediatr, 10.1111/apa.15270

Schulze-Koops, 2020, Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/Covid-19 pandemic, Ann Rheum Dis, 10.1136/annrheumdis-2020-217628

Wang, 2020, Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures, J Med Virol

Fu, 2020, Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis, J Infect, 10.1016/j.jinf.2020.03.041

Yang, 2020, Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis, Int J Infect Dis, 10.1016/j.ijid.2020.03.017

Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep. 2020;69 (13):382-6.

Doran, 2002, Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study, Arthritis Rheum, 46, 2287, 10.1002/art.10524

Au, 2011, High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis, Ann Rheum Dis, 70, 785, 10.1136/ard.2010.128637

Dixon, 2012, Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis, Ann Rheum Dis, 71, 1128, 10.1136/annrheumdis-2011-200702

Lighter, 2020, Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission, Clin Infect Dis, 10.1093/cid/ciaa415

Ye, 2020, Cytokine Storm in COVID-19 and Treatment, J Infect, 10.1016/j.jinf.2020.03.037

Fu, 2020, Why tocilizumab could be an effective treatment for severe COVID-19?, J Transl Med., 18, 164, 10.1186/s12967-020-02339-3

McGonagle, 2020, The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease, Autoimmun Rev, 10.1016/j.autrev.2020.102537

Manfredi, 2019, Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study, Intern Med J

Fernandez-Diaz, 2018, Abatacept in patients with rheumatoid arthritis and interstitial lung disease: a national multicenter study of 63 patients, Semin Arthritis Rheum, 48, 22, 10.1016/j.semarthrit.2017.12.012

Singh, 2011, Adverse effects of biologics: a network meta-analysis and Cochrane overview, Cochrane Database Syst Rev, 2011

European League Against Rheumatism (EULAR). EULAR COVID-19 database. Available from: https://www.eular.org/eular_covid19_database.cfm. [Accessed April 28 2020].